JUNEVITY

Serial Number 98117779
731

Registration Progress

Application Filed
Aug 4, 2023
Under Examination
Jan 14, 2025
Approved for Publication
Dec 3, 2024
Published for Opposition
Dec 3, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jul 14, 2026 172 days

Trademark Image

JUNEVITY

Basic Information

Serial Number
98117779
Filing Date
August 4, 2023
Published for Opposition
December 3, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Jan 8, 2026
Application
Pending
Classes
005 042

Rights Holder

Junevity, Inc.

03
Address
135 Mississippi Street
San Francisco, CA 94107

Ownership History

Junevity, Inc.

Original Applicant
03
San Mateo, CA

Junevity, Inc.

Owner at Publication
03
San Francisco, CA

Legal Representation

Attorney
Christina M. Licursi

USPTO Deadlines

Next Deadline
172 days remaining
NOA E-Mailed - SOU Required
Due Date
July 14, 2026
Extension Available
Until January 14, 2027

Application History

27 events
Date Code Type Description Documents
Jan 9, 2026 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 8, 2026 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 8, 2026 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 8, 2026 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 22, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 22, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 22, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 22, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 22, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 27, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 27, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
May 27, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 14, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 3, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 3, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 27, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 11, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 14, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 13, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 13, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 22, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 22, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 22, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 5, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 3, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 8, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of human diseases and disorders, namely, metabolic disease, liver diseases, diabetes, obesity, muscle wasting and frailty, dementia and neurological diseases, skin diseases, chronic kidney disease, inflammatory diseases, and lung diseases; pharmaceutical preparations for the treatment of physiological diseases; pharmaceutical products for cell therapy to treat human diseases and disorders, as well as aging; cell therapy products, namely, pharmaceutical preparations for cell therapy to treat human aging, diseases, and disorders, namely, metabolic disease, liver diseases, diabetes, obesity, muscle wasting and frailty, dementia and neurological diseases, skin diseases, chronic kidney disease, inflammatory diseases, and lung diseases; pharmaceutical preparations for gene therapy to treat human diseases and disorders; pharmaceutical gene therapy preparations to treat human diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for gene and cell therapy
Class 042
Research and development in the field of pharmaceutical development; medical and scientific research and development in connection with cell aging and restoration; research and development of new products in the pharmaceutical and biotechnology fields; development of new technology for others in the fields of gene therapy, genome writing, and genome engineering; scientific research and development in the field of pharmaceutical preparations for gene therapy; scientific research and development in the field of enzyme preparations for gene and cell therapy; research and development services in the field of genomics; medical and scientific research in the fields of genomics; providing medical and scientific research information in the fields of genomics; medical and scientific research in the field of genetics for the purpose of elevating single cell genome variants in order to identify transcription factors; scientific research and development and scientific research consulting, all in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing medical research information in the field of genomics in relation to disease treatment and aging; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the field of genomics; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the field of genomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the field of genomics; providing temporary use of non-downloadable computer software incorporating machine learning (ML) and artificial intelligence (AI) technology for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software incorporating machine learning (ML) and artificial intelligence (AI) technology for medical and scientific research in the field of genomics; providing temporary use of non-downloadable computer software for providing medical and scientific research information in the field of genomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with detecting variants in cells to treat disease and mitigate aging; providing temporary use of non-downloadable computer software for research, development and consultancy in the field of genomics; providing temporary use of non-downloadable computer software for compiling data for research purposes in the field of genomics; providing temporary use of non-downloadable computer software for providing medical research information in the field of genomics; providing temporary use of non-downloadable computer software for medical testing, diagnosis, and treatment; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of genomics for the purpose of disease treatment; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of genomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with aging

Classification

International Classes
005 042